Concepedia

H Kropp

HK

25

Publications

3K

Citations

20

H-Index

1969

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

H Kropp is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, pharmacology, and drug resistance.

Top concepts

Publications per year

1969–1999

25

Publications

25

THE MECHANISM OF ACTION OF FOSFOMYCIN (PHOSPHONOMYCIN)

Frederick M. Kahan, Jean S. Kahan, Patrick J. Cassidy et al. · Annals of the New York Academy of Sciences · 1974 · 777 citations

, , +5

Metabolism of Thienamycin and Related Carbapenem Antibiotics by the Renal Dipeptidase, Dehydropeptidase-I

H Kropp, Jon G. Sundelof, Richard Hajdu et al. · Antimicrobial Agents and Chemotherapy · 1982 · 338 citations · Full text

Carbapenems, a new class of beta-lactam antibiotics

Jerome Birnbaum, Frederick M. Kahan, H Kropp et al. · The American Journal of Medicine · 1985 · 288 citations

, , +5

Evaluation of the echinocandin antifungal MK-0991 (L-743,872): efficacies in mouse models of disseminated aspergillosis, candidiasis, and cryptococcosis

George K. Abruzzo, Amy Flattery, Christopher Gill et al. · Antimicrobial Agents and Chemotherapy · 1997 · 244 citations · Full text

MK0787 (N-formimidoyl thienamycin): evaluation of in vitro and in vivo activities

H Kropp, Jon G. Sundelof, Jean S. Kahan et al. · Antimicrobial Agents and Chemotherapy · 1980 · 193 citations · Full text

, , +18

Rows per page

1–5 of 25